Latest Breaking News On - Elan pharmaceuticals inc - Page 1 : comparemela.com

FDA Approves First Biosimilar of Natalizumab for the Treatment of Relapsing Multiple Sclerosis

The FDA is the first regulatory agency globally to approve natalizumab-sztn as a biosimilar for natalizumab.

Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., to Its Board of Directors

TORONTO, June 27, 2023 (GLOBE NEWSWIRE)

VETmAb Biosciences' Bow-Wow Biz - San Diego Business Journal

Sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

Mindera Health™ Announces Change to Executive Leadership

Ron Rocca to Become Chief Executive Officer.

Stock Market | FinancialContent Business Page